Vantedge Medical Buys Hobson & Motzer

Vantedge Medical, a portfolio company of Aterian Investment Partners, has acquired Hobson & Motzer.
 
Hobson, founded in 1912 and based in Connecticut, manufactures precision medical devices for the surgical stapler market. All of its sales stream comes from medical consumable devices. Its highly automated facilities house progressive stamping, precision electrochemical machining, coined wire as well as tool and die capabilities.
 
Hobson is the fifth medtech add-on acquisition for Vantedge since 2018.
 
Vantedge said acquiring Hobson strengthens its position as a manufacturing partner to blue-chip medical OEMs and bolsters its consumable portfolio offering. The company now operates nine facilities in the U.S. with over 1,200 employees.
 
“It gives me great pleasure to announce the union of Vantedge Medical and Hobson & Motzer,” said Vantedge chairman and CEO Brian King. “I have worked with the Hobson & Motzer team for many years, and they consistently delivered best-in-class quality, service, value, and innovation. Their depth and scale of capabilities, backed by over 100 years of experience, perfectly complements the existing Vantedge capabilities, enhances the value we bring to the world’s leading medical technology companies, and amplifies the difference we are making in the lives of patients and their families.”
 
“As I contemplated transitioning the company to new ownership, my key requirements were to find a company that shared our commitment to quality, service and innovation, had deep experience in the MedTech space and viewed our capabilities as enablers for growth,” added Hobson & Motzer president and owner Bruce Dworak. “Vantedge Medical met these criteria in every way. I look forward to the continuing legacy of performance and market leadership, just at a much larger scale.”